Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Could a common heart drug be the key to reversing fatty liver disease?

NCT ID NCT06588699

First seen Nov 01, 2025 · Last updated May 18, 2026 · Updated 30 times

Summary

This study tests if a low dose of digoxin, a drug currently used for heart conditions, can help people with NASH (a severe type of fatty liver disease). About 144 adults with NASH and liver scarring will take oral digoxin for a period. The goal is to see if the drug can reverse the liver inflammation and fat buildup without making the scarring worse.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MASLD are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Email: •••••@•••••

Locations

  • Yale New Haven Health

    RECRUITING

    New Haven, Connecticut, 06510, United States

    Contact Email: •••••@•••••

    Contact Email: •••••@•••••

    Contact

  • Yale New Haven Hospital

    RECRUITING

    New Haven, Connecticut, 06510, United States

    Contact Email: •••••@•••••

    Contact Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.